Role of Chinese Herbal Medicines in Regulation of Energy Metabolism in Treating Cardiovascular Diseases

Osthole Inhibits Expression of Genes Associated with Toll-like Receptor 2 Signaling Pathway in an Organotypic 3D Skin Model of Human Epidermis with Atopic Dermatitis

“…The compounds used in Chinese medicine are known to significantly improve the disease state, alleviate the disease progression, shorten the time to disease recurrence and improve the quality of life of patients. Therefore, herbal remedies are increasingly recommended in clinical practice due to their remarkable therapeutic effects in numerous diseases [ 59 ].…”

Yiqi Huoxue preserves heart function by upregulating the Sigma‑1 receptor in rats with myocardial infarction

“…In HF, a deficit in energy may account for the contractile dysfunction observed during maximal exertion (5). In traditional Chinese medicine, QiShenYiQi and Qiliqiangxin, which are manufactured using YQHX, have been suggested to ameliorate the symptoms of disorders in cardiac structure and function, possibly via an increase in the myocardial ATP content (20)(21)(22). Studies on the major active ingredients of Astragalus, a drug used in the formulation of YQHX, including Astragaloside IV and Astragalus polysaccharide, have been proven to regulate mitochondrial function and energy biosynthesis (23,24).…”

Shenfu Injection Promotes Vasodilation by Enhancing eNOS Activity Through the PI3K/Akt Signaling Pathway In Vitro

“…Although more and more singlecomponent and single-target chemical medicines are being developed, it is still difficult to prevent the increasing rate of morbidity and mortality of CVD; this may be because of serious adverse reactions and high medical costs. Traditional Chinese medicine and its compound may have advantages in treating CVD owing to its multi-component, multi-target, multi-effect features (Dong et al, 2017;Li et al, 2019).…”